Drug intelligence / Profile preview

avocadene

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intranasal, Parenteral
01

Overview

Avocadene is a **polyhydroxylated fatty alcohol** (17-carbon, also known as 16-heptadecene-1,2,4-triol) classified within the acetogenin family and is predominantly found in avocado (Persea americana). Its structure is characterized by multiple hydroxyl groups and an unsaturated fatty acid tail, allowing it to modulate mitochondrial metabolism. The primary **mechanism of action** is the inhibition of fatty acid oxidation (FAO), specifically through targeting mitochondrial enzymes such as very long-chain acyl-CoA dehydrogenase (VLCAD). This leads to disruption of energy metabolism and induction of selective apoptosis in cancer cells, particularly acute myeloid leukemia (AML), while sparing healthy cells. Preclinical studies have also suggested additional roles in reversing insulin resistance linked to obesity, exhibiting antimicrobial properties against certain Gram-positive bacteria, and possibly impeding viral replication. Research is ongoing into its applications as an anti-cancer and immunomodulatory agent, but it is not currently an approved pharmaceutical and remains under investigation for these indications[1][4][9].

Other names
16-heptadecene-1,2,4-triol
02

Targets

VLCAD (Very long-chain acyl-CoA dehydrogenase)FASN (Fatty acid synthase)

Beyond the preview

Go deeper on avocadene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on avocadene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call